CORONA : RECEIVES ANVISA GMP CERTIFICATION FOR BHAYLA FACILITY

• ANVISA (Brazil) GMP certification received for Bhayla, Ahmedabad facility covering Oral Solid Dosage and Women's Hormone production lines • Marks third major GMP accreditation after EU-GMP approvals for Women's Hormone and OSD facilities and EAEU-GMP certification for the OSD facility • India remains the primary market, contributing over 96% of company revenue • Brazil is one of the largest pharma markets in Latin America, estimated at USD 44 billion • Accredited facility supports the company's One World, One Quality quality-compliance positioning across manufacturing operations

CORONA Remedies Limited

Open attachment

← Back to feed